by Drs. Pan, Doctor & Spinella
at Washington University in St. Louis (WUSTL)
- Bench Pilot Work
Formulation demonstrates key requirements
Novel transfusion models - First in vivo POC
Efficacy for hemorrhagic shock and 70% blood exchange
Formulation ErythroMer (EM) V1 - First Funding & Support
Children’s Discovery Institute OAIF Grant ($1M)
Invention Disclosure (WUSTL)
Bear Cub award ($75K) - Incubator Program: BioGenerator Fundamentals